Osteoblastic glucocorticoid signaling exacerbates high-fat-diet- induced bone loss and obesity

Abstract

Chronic high-fat diet (HFD) consumption not only promotes obesity and insulin resistance, but also causes bone loss through mechanisms that are not well understood. Here, we fed wild-type CD-1 mice either chow or a HFD (43% of energy from fat) for 18 weeks; HFD-fed mice exhibited decreased trabecular volume (−28%) and cortical thickness (−14%) compared to chow-fed mice. In HFD-fed mice, bone loss was due to reduced bone formation and mineral apposition, without obvious effects on bone resorption. HFD feeding also increased skeletal expression of sclerostin and caused deterioration of the osteocyte lacunocanalicular network (LCN). In mice fed HFD, skeletal glucocorticoid signaling was activated relative to chow-fed mice, independent of serum corticosterone concentrations. We therefore examined whether skeletal glucocorticoid signaling was necessary for HFD-induced bone loss, using transgenic mice lacking glucocorticoid signaling in osteoblasts and osteocytes (HSD2^OB/OCY-tg mice). In HSD2^OB/OCY-tg mice, bone formation and mineral apposition rates were not suppressed by HFD, and bone loss was significantly attenuated. Interestingly, in HSD2^OB/OCY-tg mice fed HFD, both Wnt signaling (less sclerostin induction, increased β-catenin expression) and glucose uptake were significantly increased, relative to diet- and genotype-matched controls. The osteocyte LCN remained intact in HFD-fed HSD2^OB/OCY-tg mice. When fed a HFD, HSD2^OB/OCY-tg mice also increased their energy expenditure and were protected against obesity, insulin resistance, and dyslipidemia. Therefore, glucocorticoid signaling in osteoblasts and osteocytes contributes to the suppression of bone formation in HFD-fed mice. Skeletal glucocorticoid signaling is also an important determinant of glucose uptake in bone, which influences the whole-body metabolic response to HFD.

References

[1] Hariri N, Thibault L. High-fat diet-induced obesity in animal models. Nutr. Res. Rev., 2010, 23: 270-299

[2] Hedeskov CJ, Capito K, Islin H, Hansen SE, Thams P. Long-term fat-feeding-induced insulin resistance in normal NMRI mice: postreceptor changes of liver, muscle and adipose tissue metabolism resembling those of type 2 diabetes. Acta Diabetol., 1992, 29: 14-19

[3] Paigen B. Genetics of responsiveness to high-fat and high-cholesterol diets in the mouse. Am. J. Clin. Nutr., 1995, 62: 458S-462S

[4] Cao JJ, Gregoire BR, Gao H. High-fat diet decreases cancellous bone mass but has no effect on cortical bone mass in the tibia in mice. Bone, 2009, 44: 1097-1104

[5] Kyung TW, Lee JE, Phan TV, Yu R, Choi HS. Osteoclastogenesis by bone marrow-derived macrophages is enhanced in obese mice. J. Nutr., 2009, 139: 502-506

[6] Patsch JM et al. Increased bone resorption and impaired bone microarchitecture in short-term and extended high-fat diet-induced obesity. Metabolism, 2011, 60: 243-249

[7] Fujita Y, Watanabe K, Maki K. Serum leptin levels negatively correlate with trabecular bone mineral density in high-fat diet-induced obesity mice. J. Musculoskelet. Neuronal Interact., 2012, 12: 84-94

[8] Lecka-Czernik B, Stechschulte LA, Czernik PJ, Dowling AR. High bone mass in adult mice with diet-induced obesity results from a combination of initial increase in bone mass followed by attenuation in bone formation; implications for high bone mass and decreased bone quality in obesity. Mol. Cell Endocrinol., 2015, 410: 35-41

[9] Scheller EL et al. Changes in skeletal integrity and marrow adiposity during high-fat diet and after weight loss. Front Endocrinol., 2016, 7: 102

[10] Beier EE et al. Effects of combined exposure to lead and high-fat diet on bone quality in juvenile male mice. Environ. Health Perspect., 2015, 123: 935-943

[11] Tencerova M et al. High-fat diet-induced obesity promotes expansion of bone marrow adipose tissue and impairs skeletal stem cell functions in mice. J. Bone Min. Res., 2018, 33: 1154-1165

[12] Corwin RL, Hartman TJ, Maczuga SA, Graubard BI. Dietary saturated fat intake is inversely associated with bone density in humans: analysis of NHANES III. J. Nutr., 2006, 136: 159-165

[13] Orchard TS et al. Fatty acid consumption and risk of fracture in the Women’s Health Initiative. Am. J. Clin. Nutr., 2010, 92: 1452-1460

[14] Ionova-Martin SS et al. Changes in cortical bone response to high-fat diet from adolescence to adulthood in mice. Osteoporos. Int., 2011, 22: 2283-2293

[15] Inzana JA et al. Immature mice are more susceptible to the detrimental effects of high fat diet on cancellous bone in the distal femur. Bone, 2013, 57: 174-183

[16] Ramamoorthy S, Cidlowski JA. Corticosteroids: mechanisms of action in health and disease. Rheum. Dis. Clin. N. Am., 2016, 42: 15-31, vii

[17] van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos. Int., 2002, 13: 777-787

[18] den Uyl D, Bultink IE, Lems WF. Glucocorticoid-induced osteoporosis. Clin. Exp. Rheumatol., 2011, 29: S93-S98

[19] Henneicke H et al. Chronic mild stress causes bone loss via an osteoblast-specific glucocorticoid-dependent mechanism. Endocrinology, 2017, 158: 1939-1950

[20] Tomlinson JW et al. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr. Rev., 2004, 25: 831-866

[21] Kotelevtsev Y et al. 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc. Natl Acad. Sci. U. S. A., 1997, 94: 14924-14929

[22] Sher LB et al. Transgenic expression of 11beta-hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone. Endocrinology, 2004, 145: 922-929

[23] Sher LB, Harrison JR, Adams DJ, Kream BE. Impaired cortical bone acquisition and osteoblast differentiation in mice with osteoblast-targeted disruption of glucocorticoid signaling. Calcif. Tissue Int., 2006, 79: 118-125

[24] Henneicke H et al. Skeletal glucocorticoid signalling determines leptin resistance and obesity in aging mice. Mol. Metab., 2020, 42: 101098

[25] Shi X et al. A glucocorticoid-induced leucine-zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells. EMBO Rep., 2003, 4: 374-380

[26] Kalak R et al. Endogenous glucocorticoid signalling in osteoblasts is necessary to maintain normal bone structure in mice. Bone, 2009, 45: 61-67

[27] Maupin KA, Droscha CJ, Williams BO. A comprehensive overview of skeletal phenotypes associated with alterations in Wnt/beta-catenin signaling in humans and mice. Bone Res., 2013, 1: 27-71

[28] Ferron M et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell, 2010, 142: 296-308

[29] Fulzele K et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell, 2010, 142: 309-319

[30] Esen E et al. WNT-LRP5 signaling induces Warburg effect through mTORC2 activation during osteoblast differentiation. Cell Metab., 2013, 17: 745-755

[31] Regan JN et al. Up-regulation of glycolytic metabolism is required for HIF1alpha-driven bone formation. Proc. Natl Acad. Sci. U. S. A., 2014, 111: 8673-8678

[32] Guntur AR, Le PT, Farber CR, Rosen CJ. Bioenergetics during calvarial osteoblast differentiation reflect strain differences in bone mass. Endocrinology, 2014, 155: 1589-1595

[33] Wei J et al. Glucose uptake and Runx2 synergize to orchestrate osteoblast differentiation and bone formation. Cell, 2015, 161: 1576-1591

[34] Lee SY, Long F. Notch signaling suppresses glucose metabolism in mesenchymal progenitors to restrict osteoblast differentiation. J. Clin. Invest., 2018, 128: 5573-5586

[35] Chen H et al. Increased glycolysis mediates Wnt7b-induced bone formation. FASEB J., 2019, 33: 7810-7821

[36] Mabilleau G, Perrot R, Flatt PR, Irwin N, Chappard D. High fat-fed diabetic mice present with profound alterations of the osteocyte network. Bone, 2016, 90: 99-106

[37] Schrauwen P. High-fat diet, muscular lipotoxicity and insulin resistance. Proc. Nutr. Soc., 2007, 66: 33-41

[38] Buettner R, Scholmerich J, Bollheimer LC. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity, 2007, 15: 798-808

[39] Bray GA, Popkin BM. Dietary fat intake does affect obesity!. Am. J. Clin. Nutr., 1998, 68: 1157-1173

[40] Shu L et al. High-fat diet causes bone loss in young mice by promoting osteoclastogenesis through alteration of the bone marrow environment. Calcif. Tissue Int., 2015, 96: 313-323

[41] Zhou H, Mak W, Zheng Y, Dunstan CR, Seibel MJ. Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling. J. Biol. Chem., 2008, 283: 1936-1945

[42] Dirckx N et al. Vhl deletion in osteoblasts boosts cellular glycolysis and improves global glucose metabolism. J. Clin. Invest., 2018, 128: 1087-1105

[43] Wei J et al. Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation. J. Clin. Invest., 2014, 124: 1-13

[44] Li Z et al. Glucose transporter-4 facilitates insulin-stimulated glucose uptake in osteoblasts. Endocrinology, 2016, 157: 4094-4103

[45] Lee NK et al. Endocrine regulation of energy metabolism by the skeleton. Cell, 2007, 130: 456-469

[46] Mosialou I et al. MC4R-dependent suppression of appetite by bone-derived lipocalin 2. Nature, 2017, 543: 385-390

[47] Yoshikawa Y et al. Genetic evidence points to an osteocalcin-independent influence of osteoblasts on energy metabolism. J. Bone Min. Res., 2011, 26: 2012-2025

[48] Frey JL et al. Wnt-Lrp5 signaling regulates fatty acid metabolism in the osteoblast. Mol. Cell Biol., 2015, 35: 1979-1991

[49] Fulzele K et al. Osteocyte-secreted Wnt signaling inhibitor sclerostin contributes to beige adipogenesis in peripheral fat depots. J. Bone Min. Res., 2017, 32: 373-384

[50] Yao Q et al. Wnt/beta-catenin signaling in osteoblasts regulates global energy metabolism. Bone, 2017, 97: 175-183

[51] Ohnaka K, Tanabe M, Kawate H, Nawata H, Takayanagi R. Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts. Biochem. Biophys. Res. Commun., 2005, 329: 177-181

[52] Yun SI, Yoon HY, Jeong SY, Chung YS. Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3beta. J. Bone Min. Metab., 2009, 27: 140-148

[53] Yao W et al. Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice. Arthritis Rheum., 2008, 58: 1674-1686

[54] Beier EE et al. Sclerostin activity plays a key role in the negative effect of glucocorticoid signaling on osteoblast function in mice. Bone Res., 2017, 5: 17013

[55] Baek K et al. TNF-alpha upregulates sclerostin expression in obese mice fed a high-fat diet. J. Cell Physiol., 2014, 229: 640-650

[56] Kim SP et al. Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes. Proc. Natl Acad. Sci. U. S. A., 2017, 114: E11238-E11247

[57] Ingvorsen C, Karp NA, Lelliott CJ. The role of sex and body weight on the metabolic effects of high-fat diet in C57BL/6N mice. Nutr. Diabetes, 2017, 7: e261

[58] Gasparini SJ et al. Androgens sensitise mice to glucocorticoid-induced insulin resistance and fat accumulation. Diabetologia, 2019, 62: 1463-1477

[59] Ducy P et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell, 2000, 100: 197-207

[60] Park JS et al. A novel 11beta-HSD1 inhibitor improves diabesity and osteoblast differentiation. J. Mol. Endocrinol., 2014, 52: 191-202

[61] Rosenstock J et al. The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy. Diabetes Care, 2010, 33: 1516-1522

[62] Sims NA et al. Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J. Clin. Invest., 2000, 106: 1095-1103

[63] Hocking SL et al. Subcutaneous fat transplantation alleviates diet-induced glucose intolerance and inflammation in mice. Diabetologia, 2015, 58: 1587-1600

[64] Simanainen U et al. Long-term corticosterone treatment induced lobe-specific pathology in mouse. Prostate, 2011, 71: 289-297

Funding

Department of Health | National Health and Medical Research Council (NHMRC)(APP1185915)